Status:
UNKNOWN
Adverse Effects of Ivermectin Used in Egypt During COVID-19
Lead Sponsor:
Menoufia University
Conditions:
Covid19
Ivermectin Poisoning
Eligibility:
All Genders
16-80 years
Brief Summary
retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt
Detailed Description
ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many pati...
Eligibility Criteria
Inclusion
- all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in egypt with explained dose
Exclusion
- \-
Key Trial Info
Start Date :
February 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04747678
Start Date
February 3 2021
End Date
March 1 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Mansour
Shibīn al Kawm, Menoufia, Egypt, 24222